Sanofi inks US$1.2 billion vaccine licensing deal with Novavax
Sanofi and Novavax signed a licensing agreement that includes commercialising a combined Covid-19 and flu shot. Novavax will receive US$500 million ...
Tag: Vaccine
AstraZeneca says it will withdraw Covid-19 vaccine globally as demand dips
ASTRAZENECA said on Tuesday (May 7) it had initiated the worldwide withdrawal of its Covid-19 vaccine due to a “surplus ...
Pfizer lifts 2024 profit view on cost cuts, higher Covid vaccine demand
PFIZER lifted its annual profit forecast on Wednesday (May 1), banking on cost cuts and better-than-expected demand for its Covid ...
AstraZeneca Admits in Court for the First Time Its Covid Vaccine Can Cause Rare Side Effect in Legal Fight with Victims of ‘Defective’ Jab
AstraZeneca has admitted in court for the first time that its Covid vaccine can lead to a severe blood clotting ...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday (Apr 25), accusing them of infringing GSK patents related ...
Moderna Is Suing Pfizer and BioNTech Over Covid Vaccine
Moderna on Friday announced in a press release it was suing Pfizer and BioNTech for patent infringement over intellectual property ...
Dr. B Review: Did the Vaccine Waitlist Make a Difference?
When the initial COVID-19 vaccine rollout happened in the United States, finding a leftover dose seemed to be the “golden ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.